Moleculin Biotech, Inc. Basic Shares Outstanding (Weighted Average)
Moleculin Biotech, Inc. (MBRX) reported Basic Shares Outstanding (Weighted Average) of 5.68 million shares for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-13.
Financial Statements › Income Statement › Earnings Per Share
us-gaap:WeightedAverageNumberOfSharesOutstandingBasic · last filed 2026-08-13
- Moleculin Biotech, Inc. weighted average number of shares outstanding, basic for the quarter ending 2026-06-30 was 5.68M shares, a 814.69% increase year-over-year.
- Moleculin Biotech, Inc. weighted average number of shares outstanding, basic for the quarter ending 2026-03-31 was 4.12M shares, a 1003.54% increase year-over-year.
- Moleculin Biotech, Inc. weighted average number of shares outstanding, basic for the quarter ending 2025-12-31 was -57.74M shares.
- Moleculin Biotech, Inc. weighted average number of shares outstanding, basic for the quarter ending 2025-09-30 was 37.30M shares, a 904.35% increase year-over-year.
- Moleculin Biotech, Inc. weighted average number of shares outstanding, basic for fiscal 2025 was 1.18M shares, a 760.13% increase from fiscal 2024.
- Moleculin Biotech, Inc. weighted average number of shares outstanding, basic for fiscal 2024 was 137.72K shares, a 93.03% decline from fiscal 2023.
- Moleculin Biotech, Inc. weighted average number of shares outstanding, basic for fiscal 2023 was 1.98M shares, a 3.60% increase from fiscal 2022.
- Moleculin Biotech, Inc. weighted average number of shares outstanding, basic for fiscal 2022 was 1.91M shares, a 92.90% decline from fiscal 2021.
| Period end | Weighted Average Number of Shares Outstanding, Basic 3 month | Weighted Average Number of Shares Outstanding, Basic 3 month as first filed | Weighted Average Number of Shares Outstanding, Basic 6 month | Weighted Average Number of Shares Outstanding, Basic 6 month as first filed | Weighted Average Number of Shares Outstanding, Basic 9 month | Weighted Average Number of Shares Outstanding, Basic 9 month as first filed | Weighted Average Number of Shares Outstanding, Basic 12 month | Weighted Average Number of Shares Outstanding, Basic 12 month as first filed |
|---|---|---|---|---|---|---|---|---|
| 2026-06-30 | 5.68M shares 10-Q · filed 2026-08-13 | 4.91M shares 10-Q · filed 2026-08-13 | -15.98M shares derived: average of 3 quarters · filed 2026-08-13 | -2.66M shares derived: average of 4 quarters · filed 2026-08-13 | ||||
| 2026-03-31 | 4.12M shares 10-Q · filed 2026-05-14 | -26.81M shares derived: average of 2 quarters · filed 2026-05-14 | -5.44M shares derived: average of 3 quarters · filed 2026-05-14 | -3.92M shares derived: average of 4 quarters · filed 2026-08-13 | ||||
| 2025-12-31 | -57.74M shares derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-18 | -10.22M shares derived: average of 2 quarters · filed 2026-03-18 | -6.61M shares derived: average of 3 quarters · filed 2026-08-13 | 1.18M shares 10-K · filed 2026-03-18 | ||||
| 2025-09-30 | 37.30M shares 10-Q · filed 2025-11-13 | 18.96M shares derived: average of 2 quarters · filed 2026-08-13 | 20.83M shares 10-Q · filed 2025-11-13 | 7.53M shares derived: average of 4 quarters · filed 2026-08-13 | ||||
| 2025-06-30 | 621.06K shares 10-Q · filed 2026-08-13 | 15.53M shares 10-Q · filed 2025-08-12 | 498.09K shares 10-Q · filed 2026-08-13 | 12.45M shares 10-Q · filed 2025-08-12 | -2.40M shares derived: average of 3 quarters · filed 2026-08-13 | -868.14K shares derived: average of 4 quarters · filed 2026-08-13 | ||
| 2025-03-31 | 373.75K shares 10-Q · filed 2026-05-14 | 9.34M shares 10-Q · filed 2025-05-13 | -3.90M shares derived: average of 2 quarters · filed 2026-05-14 | -1.36M shares derived: average of 3 quarters · filed 2026-05-14 | -387.59K shares derived: average of 4 quarters · filed 2026-05-14 | |||
| 2024-12-31 | -8.18M shares derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-18 | -2.23M shares derived: average of 2 quarters · filed 2026-03-18 | -641.37K shares derived: average of 3 quarters · filed 2026-03-18 | 137.72K shares 10-K · filed 2026-03-18 | 3.44M shares 10-K · filed 2025-03-21 | |||
| 2024-09-30 | 3.71M shares 10-Q · filed 2025-11-13 | 3.13M shares derived: average of 2 quarters · filed 2025-11-13 | 2.91M shares 10-Q · filed 2025-11-13 | 2.69M shares derived: average of 4 quarters · filed 2025-11-13 | ||||
| 2024-06-30 | 2.54M shares 10-Q · filed 2025-08-12 | 2.50M shares 10-Q · filed 2025-08-12 | 2.34M shares derived: average of 3 quarters · filed 2025-08-12 | 2.25M shares derived: average of 4 quarters · filed 2025-08-12 | ||||
| 2024-03-31 | 2.47M shares 10-Q · filed 2025-05-13 | 2.24M shares derived: average of 2 quarters · filed 2025-05-13 | 2.16M shares derived: average of 3 quarters · filed 2025-05-13 | 2.11M shares derived: average of 4 quarters · filed 2025-05-13 | ||||
| 2023-12-31 | 2.02M shares derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-21 | 2.00M shares derived: average of 2 quarters · filed 2025-03-21 | 2.00M shares derived: average of 3 quarters · filed 2025-03-21 | 1.98M shares 10-K · filed 2025-03-21 | ||||
| 2023-09-30 | 1.99M shares 10-Q · filed 2024-11-08 | 29.81M shares 10-Q · filed 2023-11-13 | 1.98M shares derived: average of 2 quarters · filed 2024-11-08 | 1.96M shares 10-Q · filed 2024-11-08 | 29.42M shares 10-Q · filed 2023-11-13 | -18.07M shares derived: average of 4 quarters · filed 2024-11-08 | ||
| 2023-06-30 | 1.98M shares 10-Q · filed 2024-08-13 | 29.69M shares 10-Q · filed 2023-08-10 | 1.95M shares 10-Q · filed 2024-08-13 | 29.22M shares 10-Q · filed 2023-08-10 | -24.76M shares derived: average of 3 quarters · filed 2024-08-13 | -11.41M shares derived: average of 4 quarters · filed 2024-08-13 | ||
| 2023-03-31 | 1.92M shares 10-Q · filed 2024-05-10 | 28.75M shares 10-Q · filed 2023-05-10 | -38.12M shares derived: average of 2 quarters · filed 2024-05-10 | -15.87M shares derived: average of 3 quarters · filed 2024-05-10 | -4.76M shares derived: average of 4 quarters · filed 2024-05-10 | |||
| 2022-12-31 | -78.16M shares derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-22 | -24.77M shares derived: average of 2 quarters · filed 2024-03-22 | -6.98M shares derived: average of 3 quarters · filed 2024-03-22 | 1.91M shares 10-K · filed 2024-03-22 | 28.60M shares 10-K · filed 2023-03-22 | |||
| 2022-09-30 | 28.63M shares 10-Q · filed 2023-11-13 | 28.61M shares derived: average of 2 quarters · filed 2023-11-13 | 28.60M shares 10-Q · filed 2023-11-13 | 28.60M shares derived: average of 4 quarters · filed 2023-11-13 | ||||
| 2022-06-30 | 28.58M shares 10-Q · filed 2023-08-10 | 28.58M shares 10-Q · filed 2023-08-10 | 28.59M shares derived: average of 3 quarters · filed 2023-08-10 | 28.58M shares derived: average of 4 quarters · filed 2023-08-10 | ||||
| 2022-03-31 | 28.58M shares 10-Q · filed 2023-05-10 | 28.59M shares derived: average of 2 quarters · filed 2023-05-10 | 28.58M shares derived: average of 3 quarters · filed 2023-05-10 | 28.55M shares derived: average of 4 quarters · filed 2023-05-10 | ||||
| 2021-12-31 | 28.60M shares derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-22 | 28.58M shares derived: average of 2 quarters · filed 2023-03-22 | 28.54M shares derived: average of 3 quarters · filed 2023-03-22 | 26.88M shares 10-K · filed 2023-03-22 | ||||
| 2021-09-30 | 28.57M shares 10-Q · filed 2022-11-10 | 28.51M shares derived: average of 2 quarters · filed 2022-11-10 | 26.30M shares 10-Q · filed 2022-11-10 | |||||
| 2021-06-30 | 28.45M shares 10-Q · filed 2022-08-12 | 25.15M shares 10-Q · filed 2022-08-12 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| MetaVia Inc. (MTVA) | United States | $0.011B | -0.65 |
| KALA BIO, Inc. (KALA) | United States | $0.011B | -3.33 |
| Theriva Biologics, Inc. (TOVX) | United States | $0.011B | |
| Dare Bioscience, Inc. (DARE) | United States | $0.011B | |
| Azitra, Inc. (AZTR) | United States | $0.010B | -0.81 |
| Medicus Pharma Ltd. (MDCX) | $0.010B | ||
| KIORA PHARMACEUTICALS INC (KPRX) | United States | $0.012B | |
| Scienture Holdings, Inc. (SCNX) | United States | $0.012B | -0.38 |
| Aprea Therapeutics, Inc. (APRE) | United States | $0.010B | -0.78 |
| Phio Pharmaceuticals Corp. (PHIO) | United States | $0.012B | -0.92 |